Stock A005500 SAMJIN PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Samjin Pharmaceuticals Co., Ltd.

Equities

A005500

KR7005500004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
19,140 KRW -0.31% Intraday chart for Samjin Pharmaceuticals Co., Ltd. -2.00% -11.39%
Feb. 29 Neurophet, Inc. announced that it has received KRW 1 billion in funding from Samjin Pharmaceuticals Co., Ltd. CI
2023 Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neurophet, Inc. announced that it has received KRW 1 billion in funding from Samjin Pharmaceuticals Co., Ltd.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on June 16, 2023 has expired with 227,116 shares, representing 1.74% for KRW 4,996.59 million.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on March 24, 2023, has expired with 228,833 shares, representing 1.73% for KRW 4,995.92 million.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on June 16, 2023.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on March 24, 2023.
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on December 2, 2022.
CI
Samjin Pharmaceuticals Co., Ltd.'s Equity Buyback announced on December 2, 2022, has expired with 183,020 shares, representing 1.36% for KRW 4,993.50 million.
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
Samjin Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
Samjin Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.
CI
AriBio Co., Ltd. agreed to acquire 7.99% stake in Samjin Pharmaceuticals Co., Ltd. for KRW 30 Billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A005500 Stock
  4. News Samjin Pharmaceuticals Co., Ltd.